242 related articles for article (PubMed ID: 36495698)
21. Lack of ClC-2 Alleviates High Fat Diet-Induced Insulin Resistance and Non-Alcoholic Fatty Liver Disease.
Fu D; Cui H; Zhang Y
Cell Physiol Biochem; 2018; 45(6):2187-2198. PubMed ID: 29550812
[TBL] [Abstract][Full Text] [Related]
22. Enhanced Nrf2 activity worsens insulin resistance, impairs lipid accumulation in adipose tissue, and increases hepatic steatosis in leptin-deficient mice.
Xu J; Kulkarni SR; Donepudi AC; More VR; Slitt AL
Diabetes; 2012 Dec; 61(12):3208-18. PubMed ID: 22936178
[TBL] [Abstract][Full Text] [Related]
23. PSA controls hepatic lipid metabolism by regulating the NRF2 signaling pathway.
Huang B; Xiong X; Zhang L; Liu X; Wang Y; Gong X; Sang Q; Lu Y; Qu H; Zheng H; Zheng Y
J Mol Cell Biol; 2021 Oct; 13(7):527-539. PubMed ID: 34048566
[TBL] [Abstract][Full Text] [Related]
24. Theaphenon E prevents fatty liver disease and increases CD4+ T cell survival in mice fed a high-fat diet.
Coia H; Ma N; Hou Y; Permaul E; Berry DL; Cruz MI; Pannkuk E; Girgis M; Zhu Z; Lee Y; Rodriquez O; Cheema A; Chung FL
Clin Nutr; 2021 Jan; 40(1):110-119. PubMed ID: 32439267
[TBL] [Abstract][Full Text] [Related]
25. Hesperetin ameliorates hepatic oxidative stress and inflammation
Li J; Wang T; Liu P; Yang F; Wang X; Zheng W; Sun W
Food Funct; 2021 May; 12(9):3898-3918. PubMed ID: 33977953
[TBL] [Abstract][Full Text] [Related]
26. Liraglutide ameliorates obesity-related nonalcoholic fatty liver disease by regulating Sestrin2-mediated Nrf2/HO-1 pathway.
Han X; Ding C; Zhang G; Pan R; Liu Y; Huang N; Hou N; Han F; Xu W; Sun X
Biochem Biophys Res Commun; 2020 May; 525(4):895-901. PubMed ID: 32171530
[TBL] [Abstract][Full Text] [Related]
27. tert-Butylhydroquinone (tBHQ) protects hepatocytes against lipotoxicity via inducing autophagy independently of Nrf2 activation.
Li S; Li J; Shen C; Zhang X; Sun S; Cho M; Sun C; Song Z
Biochim Biophys Acta; 2014 Jan; 1841(1):22-33. PubMed ID: 24055888
[TBL] [Abstract][Full Text] [Related]
28. Apigenin, a modulator of PPARγ, attenuates HFD-induced NAFLD by regulating hepatocyte lipid metabolism and oxidative stress via Nrf2 activation.
Feng X; Yu W; Li X; Zhou F; Zhang W; Shen Q; Li J; Zhang C; Shen P
Biochem Pharmacol; 2017 Jul; 136():136-149. PubMed ID: 28414138
[TBL] [Abstract][Full Text] [Related]
29. NF-E2-related factor 2 deletion facilitates hepatic fatty acids metabolism disorder induced by high-fat diet via regulating related genes in mice.
Wang X; Li C; Xu S; Ishfaq M; Zhang X
Food Chem Toxicol; 2016 Aug; 94():186-96. PubMed ID: 27311796
[TBL] [Abstract][Full Text] [Related]
30. Pyridostigmine attenuated high-fat-diet induced liver injury by the reduction of mitochondrial damage and oxidative stress via α7nAChR and M3AChR.
Xue R; Wu Q; Guo L; Ye D; Cao Q; Zhang M; Xian Y; Chen M; Yan K; Zheng J
J Biochem Mol Toxicol; 2024 Mar; 38(3):e23671. PubMed ID: 38454809
[TBL] [Abstract][Full Text] [Related]
31. Plantamajoside modulates immune dysregulation and hepatic lipid metabolism in rats with nonalcoholic fatty liver disease via AMPK/Nrf2 elevation.
Wu JM; Zhaori G; Mei L; Ren XM; Laga AT; Deligen B
Kaohsiung J Med Sci; 2023 Aug; 39(8):801-810. PubMed ID: 37265208
[TBL] [Abstract][Full Text] [Related]
32. Integrated omics analysis for characterization of the contribution of high fructose corn syrup to non-alcoholic fatty liver disease in obesity.
Papadopoulos G; Legaki AI; Georgila K; Vorkas P; Giannousi E; Stamatakis G; Moustakas II; Petrocheilou M; Pyrina I; Gercken B; Kassi E; Chavakis T; Pateras IS; Panayotou G; Gika H; Samiotaki M; Eliopoulos AG; Chatzigeorgiou A
Metabolism; 2023 Jul; 144():155552. PubMed ID: 36996933
[TBL] [Abstract][Full Text] [Related]
33. Nrf2 deletion causes "benign" simple steatosis to develop into nonalcoholic steatohepatitis in mice fed a high-fat diet.
Wang C; Cui Y; Li C; Zhang Y; Xu S; Li X; Li H; Zhang X
Lipids Health Dis; 2013 Nov; 12():165. PubMed ID: 24188280
[TBL] [Abstract][Full Text] [Related]
34. High-altitude chronic hypoxia ameliorates obesity-induced non-alcoholic fatty liver disease in mice by regulating mitochondrial and AMPK signaling.
Song K; Zhang Y; Ga Q; Bai Z; Ge RL
Life Sci; 2020 Jul; 252():117633. PubMed ID: 32289432
[TBL] [Abstract][Full Text] [Related]
35. SARM1 deletion restrains NAFLD induced by high fat diet (HFD) through reducing inflammation, oxidative stress and lipid accumulation.
Pan ZG; An XS
Biochem Biophys Res Commun; 2018 Apr; 498(3):416-423. PubMed ID: 29454967
[TBL] [Abstract][Full Text] [Related]
36. Phoenixin 14 Inhibits High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Experimental Mice.
Yang F; Huang P; Shi L; Liu F; Tang A; Xu S
Drug Des Devel Ther; 2020; 14():3865-3874. PubMed ID: 33061293
[TBL] [Abstract][Full Text] [Related]
37. Steatotic Hepatocytes Release Mature VLDL Through Methionine and Tyrosine Metabolism in a Keap1-Nrf2-Dependent Manner.
Sano A; Kakazu E; Hamada S; Inoue J; Ninomiya M; Iwata T; Tsuruoka M; Sato K; Masamune A
Hepatology; 2021 Sep; 74(3):1271-1286. PubMed ID: 33724516
[TBL] [Abstract][Full Text] [Related]
38. HCBP6 deficiency exacerbates glucose and lipid metabolism disorders in non-alcoholic fatty liver mice.
Lu H; Yuan X; Zhang Y; Han M; Liu S; Han K; Liang P; Cheng J
Biomed Pharmacother; 2020 Sep; 129():110347. PubMed ID: 32535386
[TBL] [Abstract][Full Text] [Related]
39. Monkfish Peptides Mitigate High Fat Diet-Induced Hepatic Steatosis in Mice.
Ye J; Tian X; Wang Q; Zheng J; Yang Y; Xu B; Zhang S; Yuan F; Yang Z
Mar Drugs; 2022 May; 20(5):. PubMed ID: 35621963
[TBL] [Abstract][Full Text] [Related]
40. Cardiotrophin-1 eliminates hepatic steatosis in obese mice by mechanisms involving AMPK activation.
Castaño D; Larequi E; Belza I; Astudillo AM; Martínez-Ansó E; Balsinde J; Argemi J; Aragon T; Moreno-Aliaga MJ; Muntane J; Prieto J; Bustos M
J Hepatol; 2014 May; 60(5):1017-25. PubMed ID: 24362075
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]